Fig. 7From: PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, relieves airway hyperresponsiveness, mucus hypersecretion and inflammation in a murine asthma modelPP121 decreased the mRNA expression levels of inflammatory cytokines, mucins and RTKs in lung tissues. A–C The bar graph shows the different expression levels of IL-4, IL-5, TNF-α, MUC5AC, MUC5B, VEGF and VEGFR2 in the control, asthma, Dex and PP121 groups. **p < 0.01; ***p < 0.001Back to article page